ARCHIVES

NCI Director and Acting FDA Commissioner Andrew von Eschenbach Endorses Rep. E. Clay Shaw In Tour of Florida Congressman’s District. Von Eschenbach Praises Shaw’s “Leadership” In Seeking Funding For Research, Support of 2015 Goal.

This article is from The Cancer Letter archive.

Vol. 32 No. 04 | February 3, 2006

Download PDF Visit The Full Archive

Related Articles

In Brief: Gallo Lists Followup Projects For Human Cancer Virus; Zubrod Responds To Cancer Program Critics

April 11, 1975

ODAC Clarifies Standards for Maintenance In Ovarian Cancer; Nixes Olaparib in 11-2 Vote

June 27, 2014

DCT Board To Consider RFA for Clinical R01 Grants At Next Meetings

January 21, 1994

Guest Editorial: As Sequestration Becomes More Likely, Health Groups Must Make Themselves Heard

February 22, 2013

NCI Cooperative Group, Cancer Center Trials Listed

November 25, 2005

NCI Committee Attempts To Redesign Cooperative Groups Without Doing Harm

June 12, 1998